logo

This collection features FDA experts in original commentaries that are designed to improve communications between clinicians and this important federal agency. It covers a wide range of topics related to FDA's multi-faceted mission of protecting and promoting the public health by ensuring the safety and quality of medical products such as drugs, foods, and medical devices.

Latest from FDA

  • A Short Tutorial on REMS: The FDA Perspective A Short Tutorial on REMS: The FDA Perspective   Dr. Gerald Dal Pan, Acting Director of the Office of Surveillance and Epidemiology at the FDA, describes the current situation with REMS.
    FDA Expert Commentary, April 2012
  • Repairing Pelvic Organ Prolapse: What's Best? Repairing Pelvic Organ Prolapse: What's Best?   What is best practice for repair of POP?
    FDA Expert Commentary, April 2012
  • Statins: The Story Behind the Label Changes Statins: The Story Behind the Label Changes Are you up-to-date on the FDA's new labeling changes for the entire statin drug class? FDA's Deputy Director for Safety explains why these changes were made.
    FDA Expert Interview, March 2012
  • What To Do About Misleading Drug Ads What To Do About Misleading Drug Ads   The FDA can't be everywhere. What is the responsibility of healthcare providers to try and rein in misleading pharmaceutical advertisements?
    FDA Expert Commentary, December 2011
  • The Problem With Drug Shortages The Problem With Drug Shortages   How is the FDA responding to actual and potential drug shortages?
    FDA Expert Commentary, November 2011
  • Current and Future State of Drug-Eluting Stents Current and Future State of Drug-Eluting Stents   Andrew Farb and Ashley B. Boam of the FDA provide a comprehensive overview of drug-eluting stents, including the state of current approvals and future developments.
    FDA Expert Interview, October 2011
  • Surgical Fires: How They Start and How to Prevent Them Surgical Fires: How They Start and How to Prevent Them   In this FDA peer-to-peer video Stephanie Joseph and Dr. Kenneth Silverstein discuss his experience with surgical fires, which led to important and innovative improvements in preventive systems.
    FDA Expert Interview, October 2011
  • Simvastatin 80 mg: An FDA Expert Interview Simvastatin 80 mg: An FDA Expert Interview Medscape talked to the FDA's Amy Egan, MD, about drug safety communication on the 80-mg dose of simvastatin.
    FDA Expert Interview, August 2011
  • Ticagrelor: The View From the FDA Ticagrelor: The View From the FDA Ticagrelor was approved by the FDA on July 20, 2011. Dr. Stockbridge, Director of the Division of Cardiovascular and Renal Products, discusses the issues.
    FDA Expert Interview, July 2011
  • The Changes in Sunscreen Labeling The Changes in Sunscreen Labeling Recently the US Food and Drug Administration released significant changes in labeling requirements for sunscreen products. Are you providing the right information to your patients when they ask?
    FDA Expert Interview, July 2011
  • Are You Prescribing Unapproved Drugs? Are You Prescribing Unapproved Drugs?   Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA).
    FDA Expert Commentary, March 2011
  • Safe Use of Drugs Requires Reports From Clinicians Safe Use of Drugs Requires Reports From Clinicians   The Safe Use Initiative is taking aim at adverse drug events and seeks input on safety issues encountered by frontline clinicians.
    FDA Expert Commentary, February 2011
  • FDA Commissioner: "Safety Science" Key to Drug Regulation
    Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety.
    Medscape Internal Medicine, February 10, 2011
  • Food Recalls: FDA Takes Preventive Approach
    Michael Taylor, the FDA's top food safety officer, talks with Dr. Eli Adashi about the agency's new powers and strategies for protecting the nation's food supply as well as clinicians' role in the effort.
    Medscape Internal Medicine, February 2, 2011
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.